ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 07 | February 13, 2004

Download PDF Visit The Full Archive

Related Articles

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Seven Seats Open Up On NCAB

January 17, 1986

Longer Awards, Annual Recompetition considered For “CCOP 3;” Concept to DCPC Board In January

July 15, 1988

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976